B4-102 CBCL: Hypertension and Treatment Flashcards
inhibit NaCl reabsorption in distal convoluted tubule
thiazides
preferred antihypertensive drugs in elderly
- thiazides
- Ca+ channel blockers
preferred thiazide due to long half life and proven reduction of CVD
chlorthalidone
uses for thiazides
* hypertension
* congestive heart failure
* nephrolithiasis
* nephrogenic diabetes insipidus
adverse effects: thiazides
- hypokalemic metabolic acidosis
hyponatremia - hypergluc
glycemia
lipidemia
uricemia
calcemia
potassium sparing diurectics
Keep your SEAT
Spironolactone
Eplerenone
Amiloride
Triamterene
used to counteract hypokalemia caused by loop or thiazide diuretics
potassium sparing diuretics
end in -pril
ACE inhibitors
how do ACE inhibitors lower bp?
reduced angiotensin and increased bradykinin cause vasodilation
adverse effects: ACE inhibitors
Captopril’s CATCHH
cough
angioedema
teratogen
creatinine (increased)
hyperkalemia
hypotension
first choice of treatment for hypertensive patients with
* diabetes
* chronic renal disease
* left ventricular hypertrophy
ACE inhibitors
lower BP without compromising blood supply to heart, brain, or kidneys
ACE inhibitors
do not use in combination with ARBs or direct renin inhibitor
ACE inhibitor
end in -sartan
angiotensin receptor antagonists
how do angiotensin receptor antagonists differ from ACE inhibitors?
- more specific- no bradykinin increase
- more complete inhibition
adverse effects: ARBs
- hyperkalemia
- decreased GFR
- hypotension
- teratogen
similar to ACE, without coughing/bradykinin induced effects
reduced intracellular Ca+ causing arteriolar smooth muscle relaxation
Ca+ channel blockers
do not cause reflex tachycardia
verapamil and diltiazem
verapamil
diltiazem
-dipines
Ca+ Channel blockers
- strongest vasodilators
- most likely to produce reflex tachycardia
dihyropyridines
-dipines
adverse effects: dihydropyridines
peripheral edema
flushing
dizziness
adverse effects: nondihydropyridines
verapamil and dilitiazem
- cardiac depression
- bradycardia
- AV block
- constipation
- orally active
- dose-dependent reduction of plasma renin
- dose dependent reduction of blood pressure
aliskiren
contraindications: aliskiren
- pregnancy
- do no combine with ACE inhibitors or ARB
- reduction in renal sympathetic nerve activity
- may also exert direct renal activity
clonidine
direct renin inhibitor
aliskiren
drugs that block renin secretion
clonidine
beta blockers
block intra and extra renal receptors involved in neural control of renin secretion
beta blockers
block adrenergic receptors at nerve endings
peripheral antagonists
stimulates medullary adrenergic receptors
central agonists
beta-1 selective blockers
4
- atenolol
- betaxolol
- bisoprolol
- metoprolol
beta-1 selective blockers
4
- atenolol
- betaxolol
- bisoprolol
- metoprolol
b1 selective and vasodilatory beta blockers
1
nebivolol
non selective beta blockers
2
- nadolol
- propranolol
beta blockers- intrinsic sympathomimetic activity
4
- acebutolol (b1 selective)
- penbutolol (non selective)
- pindolol (non selective)
- carteolol (non selective)
beta blockers- combined a and b receptors
2
- carvedilol (a1 antagonist, nonselective)
- labetalol (a1 antagonist, nonselective)
beta blockers lower BP by 3 mechanisms:
- reduce CO
- reduce renin secretion
- reduce sympathetic vasomotor tone
more effective in caucasian and young hypertensives
beta blockers
long term benefits on mortality and CVD when used in people with heart failure or acute MI
beta blockers
pose a significant risk of new-onset diabetes
beta blockers
can worsen symptoms of
* reduced myocardial reserve
* asthma
* peripheral vascular neuropathy
* diabetes
beta blockers
a1 antagonists
-zosins
mechanism of action: a1 antagonists
BP falls due to decreased TPR
centrally acting sympatholytic drugs
3
- clonidine
- methyldopa
- guanfacine
sudden withdrawal causes hypertensive crisis, headache, tremor, abdominal pain
clonidine